Showing results (301-310 of 883) with videos related to

Sort By:
Pageof 89
Journal of Clinical Medicine|April 30, 2020
Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide AnalysisLaurent Fauchier, Alexandre Bodin, Arnaud Bisson, et al.
Journal of the American Heart Association|May 5, 2020
Pacemaker Implantation After Balloon- or Self-Expandable Transcatheter Aortic Valve Replacement in Patients With Aortic StenosisArnaud Bisson, Alexandre Bodin, Julien Herbert, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 21, 2022
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General RegistryWern Yew Ding, Marco Proietti, Giuseppe Boriani, et al.
Heart Rhythm|June 20, 2021
Outcomes associated with pacemaker implantation following transcatheter aortic valve replacement: A nationwide cohort studyNicolas Clementy, Arnaud Bisson, Alexandre Bodin, et al.
Stroke|August 9, 2019
Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial FibrillationPatrick Blin, Laurent Fauchier, Caroline Dureau-Pournin, et al.
Mayo Clinic Proceedings|January 5, 2024
Outcomes Associated With Left Atrial Appendage Occlusion Via Implanted Device in Atrial FibrillationBaptiste Maille, Pascal Defaye, Sid Ahmed Bentounes, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 23, 2019
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort studyLaurent Fauchier, Patrick Blin, Frédéric Sacher, et al.
Thrombosis and Haemostasis|February 5, 2016
Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis. The Loire Valley Atrial Fibrillation ProjectRaphael Philippart, Anne Brunet-Bernard, Nicolas Clementy, et al.
European Journal of Preventive Cardiology|July 15, 2025
Expert Perspectives on Incorporating GLP-1 RA in Diabetes and Chronic Kidney Disease - Challenges and OpportunitiesJean-Michel Halimi, Laurent Fauchier, Alexandre Karras, et al.
Pageof 89